Page last updated: 2024-08-26

carbidopa, levodopa drug combination and Leukemia, Myelomonocytic, Acute

carbidopa, levodopa drug combination has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luque, FA; Petruska, P; Selhorst, JB1

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and Leukemia, Myelomonocytic, Acute

ArticleYear
Parkinsonism induced by high-dose cytosine arabinoside.
    Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3

    Topics: Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Middle Aged; Parkinson Disease, Secondary

1987